Adpgk nanovaccine was tested in a murine tumor model of MC38 colon carcinoma.[3b] We established MC38 colon carcinoma subcutaneously on the right flank of C57BL/6 mice, and vaccines composed of Adpgk peptides and Alexa Fluor 647 (AF647)‐tagged CpG were administered directly into tumors. Here, ADPGK is linked to colon carcinoma.